Background and aims: the aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. Methods: the in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. Results: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decrea...
Introduction: Cachexia is frequent in chronic diseases and especially during cancer development. Mul...
Background: Cancer-cachexia induces a variety of metabolic disorders, including skeletal muscle imba...
Chemotherapy can cause cachexia, which consists of weight loss associated with muscle atrophy. The e...
Abstract\ud \ud \ud \ud Background and aims...
Background: The effectiveness of drugs aimed at counteracting cancer cachexia is generally tested in...
Cancer cachexia (CC) is a debilitating multifactorial syndrome, involving progressive deterioration ...
A cachexia diagnosis is associated with a doubling in hospital stay and increased healthcare cost fo...
Background: Cachexia, a common manifestation of malignant cancer, is associated with wasting of ske...
Although there are currently no approved treatments for cancer cachexia, there is an intensified int...
Cancer cachexia is a complex wasting condition characterized by chronic inflammation, disrupted ener...
Cancer cachexia is a complex wasting condition characterized by chronic inflammation, disrupted ener...
International audienceMore than 50% of patients with advanced stages of colon cancer suffer from pro...
PURPOSE: To determine the effectiveness of the polyanionic, metal binding agent D-myo-inositol-1,2,6...
Cachexia contributes to an increased mortality rate in multiple chronic diseases such as: cancer, AI...
Introduction: Cachexia is frequent in chronic diseases and especially during cancer development. Mul...
Background: Cancer-cachexia induces a variety of metabolic disorders, including skeletal muscle imba...
Chemotherapy can cause cachexia, which consists of weight loss associated with muscle atrophy. The e...
Abstract\ud \ud \ud \ud Background and aims...
Background: The effectiveness of drugs aimed at counteracting cancer cachexia is generally tested in...
Cancer cachexia (CC) is a debilitating multifactorial syndrome, involving progressive deterioration ...
A cachexia diagnosis is associated with a doubling in hospital stay and increased healthcare cost fo...
Background: Cachexia, a common manifestation of malignant cancer, is associated with wasting of ske...
Although there are currently no approved treatments for cancer cachexia, there is an intensified int...
Cancer cachexia is a complex wasting condition characterized by chronic inflammation, disrupted ener...
Cancer cachexia is a complex wasting condition characterized by chronic inflammation, disrupted ener...
International audienceMore than 50% of patients with advanced stages of colon cancer suffer from pro...
PURPOSE: To determine the effectiveness of the polyanionic, metal binding agent D-myo-inositol-1,2,6...
Cachexia contributes to an increased mortality rate in multiple chronic diseases such as: cancer, AI...
Introduction: Cachexia is frequent in chronic diseases and especially during cancer development. Mul...
Background: Cancer-cachexia induces a variety of metabolic disorders, including skeletal muscle imba...
Chemotherapy can cause cachexia, which consists of weight loss associated with muscle atrophy. The e...